Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Certara has conducted more than 80 projects in infectious disease, including many HIV and HCV viral dynamics/kinetics modeling projects over the past decade, in all clinical development phases. We have covered critical issues in trial design, dose selection, and development strategy. We also have helped achieve IND approval for two systemic antibiotics. Our recent experience covers most mechanisms of action including protease inhibitors, NNRTIs, NRTIs, and novel mechanisms. In addition, Certara has taken a leadership role at over a dozen industry conferences, has published in peer-reviewed journals, and has other publications and collaborations in progress.
Certara Strategic Consulting uses the power of biosimulation technology to help our clients maximize knowledge of drug safety and efficacy for anti-infectives.